170 related articles for article (PubMed ID: 38170228)
1. Liver cancer-specific mutations in functional domains of ADAR2 lead to the elevation of coding and non-coding RNA editing in multiple tumor-related genes.
Li J; Li C; Xu W
Mol Genet Genomics; 2024 Jan; 299(1):1. PubMed ID: 38170228
[TBL] [Abstract][Full Text] [Related]
2. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide expression changes mediated by A-to-I RNA editing correlate with hepatic oncogenesis.
Li J; Li Q; Yu CP; Chang S; Xie LL; Wang S
Transl Cancer Res; 2021 Jun; 10(6):2725-2737. PubMed ID: 35116583
[TBL] [Abstract][Full Text] [Related]
4. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.
Liu WH; Chen CH; Yeh KH; Li CL; Wu YJ; Chen DS; Chen PJ; Yeh SH
PLoS One; 2013; 8(12):e81922. PubMed ID: 24386085
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
6. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis.
Song Y; An O; Ren X; Chan THM; Tay DJT; Tang SJ; Han J; Hong H; Ng VHE; Ke X; Shen H; Pitcheshwar P; Lin JS; Leong KW; Molias FB; Yang H; Kappei D; Chen L
J Hepatol; 2021 Jan; 74(1):135-147. PubMed ID: 32693003
[TBL] [Abstract][Full Text] [Related]
7. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide identification of RNA editing in hepatocellular carcinoma.
Kang L; Liu X; Gong Z; Zheng H; Wang J; Li Y; Yang H; Hardwick J; Dai H; Poon RT; Lee NP; Mao M; Peng Z; Chen R
Genomics; 2015 Feb; 105(2):76-82. PubMed ID: 25462863
[TBL] [Abstract][Full Text] [Related]
9. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
[TBL] [Abstract][Full Text] [Related]
10. Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
Chen J; Wang L; Wang F; Liu J; Bai Z
Front Oncol; 2020; 10():37. PubMed ID: 32117713
[TBL] [Abstract][Full Text] [Related]
11. ADAR RNA editing in human disease; more to it than meets the I.
Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
[TBL] [Abstract][Full Text] [Related]
12. RNA editome imbalance in hepatocellular carcinoma.
Qi L; Chan TH; Tenen DG; Chen L
Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
[TBL] [Abstract][Full Text] [Related]
13. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
[TBL] [Abstract][Full Text] [Related]
14. A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering microRNA target regions.
Ge F; Cao X; Jiang Y
J Appl Genet; 2023 Sep; 64(3):493-505. PubMed ID: 37542613
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.
Liu Z; Liu L; Guo C; Yu S; Meng L; Zhou X; Han X
Int Immunopharmacol; 2021 Dec; 101(Pt B):108340. PubMed ID: 34789428
[TBL] [Abstract][Full Text] [Related]
16. RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing.
Hu X; Wan S; Ou Y; Zhou B; Zhu J; Yi X; Guan Y; Jia W; Liu X; Wang Q; Qi Y; Yuan Q; Huang W; Liao W; Wang Y; Zhang Q; Xiao H; Chen X; Huang J
Cancer Lett; 2015 Feb; 357(2):510-9. PubMed ID: 25499081
[TBL] [Abstract][Full Text] [Related]
17. Novel exon of mammalian ADAR2 extends open reading frame.
Maas S; Gommans WM
PLoS One; 2009; 4(1):e4225. PubMed ID: 19156214
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression.
Śmiech M; Leszczyński P; Wardell C; Poznański P; Pierzchała M; Taniguchi H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163468
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
20. Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).
Zimonjic DB; Popescu NC
Int J Oncol; 2012 Aug; 41(2):393-406. PubMed ID: 22580498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
